Eris Lifesciences executes agreement with Kinedex Healthcare

09 Nov 2018 Evaluate

Eris Lifesciences has executed a share purchase agreement with Rakesh Dhuria, a promoter of Kinedex Healthcare, with the intent of increasing its ownership and control of the said subsidiary i.e. Kinedex by way of purchase of 12,239 equity shares of face value of Rs 10 each (equivalent to 6.71%).

Prior to this transaction, the company (including its nominees) held 75.48% shareholding in Kinedex. Post completion of this transaction, the total holding of the company (including its Nominees) shall stand at 82.19% (rounded to two decimal places).

Eris Lifesciences is engaged in manufacturing, marketing and selling of branded generics within the chronic and acute categories of the Indian Pharmaceutical Market.

Eris Lifesciences Share Price

1389.70 -22.85 (-1.62%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.